Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30M Sell
82,829
-1,723
-2% -$590K 0.23% 149
2026
Q1
$29.7M Buy
84,552
+12,647
+18% +$4.51M 0.24% 145
2025
Q4
$23.5M Buy
71,905
+57,235
+390% +$18.2M 0.18% 171
2025
Q3
$4.14M Sell
14,670
-19,260
-57% -$5.59M 0.03% 231
2025
Q2
$9.47M Sell
33,930
-10,590
-24% -$3M 0.07% 207
2025
Q1
$13.9M Buy
44,520
+5,983
+16% +$1.77M 0.1% 191
2024
Q4
$10M Sell
38,537
-243
-0.6% -$72.1K 0.07% 206
2024
Q3
$12.5M Sell
38,780
-3,930
-9% -$1.29M 0.09% 192
2024
Q2
$13.3M Sell
42,710
-890
-2% -$261K 0.1% 184
2024
Q1
$12.4M Sell
43,600
-60
-0.1% -$17.6K 0.09% 187
2023
Q4
$12.6M Sell
43,660
-290
-0.7% -$79K 0.09% 182
2023
Q3
$11.8M Buy
43,950
+4,650
+12% +$1.16M 0.1% 185
2023
Q2
$8.73M Sell
39,300
-1,555
-4% -$361K 0.07% 204
2023
Q1
$9.88M Sell
40,855
-6,850
-14% -$1.68M 0.09% 198
2022
Q4
$12.5M Buy
47,705
+11,965
+33% +$3.21M 0.11% 191
2022
Q3
$8.06M Buy
35,740
+1,205
+3% +$292K 0.08% 205
2022
Q2
$8.4M Sell
34,535
-3,842
-10% -$941K 0.08% 209
2022
Q1
$9.28M Sell
38,377
-117,946
-75% -$27.1M 0.08% 210
2021
Q4
$35.2M Sell
156,323
-17,531
-10% -$3.7M 0.28% 124
2021
Q3
$37M Sell
173,854
-20,877
-11% -$4.81M 0.33% 109
2021
Q2
$47.5M Buy
194,731
+8,530
+5% +$2.1M 0.42% 81
2021
Q1
$46.3M Buy
186,201
+26,825
+17% +$6.4M 0.45% 71
2020
Q4
$36.6M Buy
159,376
+15,746
+11% +$3.63M 0.39% 85
2020
Q3
$36.5M Buy
143,630
+129,956
+950% +$32.2M 0.45% 66
2020
Q2
$3.23M Sell
13,674
-50
-0.4% -$11.4K 0.04% 248
2020
Q1
$2.78M Sell
13,724
-122
-0.9% -$26.6K 0.04% 248
2019
Q4
$3.34M Sell
13,846
-123
-0.9% -$27.1K 0.04% 254
2019
Q3
$2.7M Sell
13,969
-366
-3% -$70.3K 0.03% 255
2019
Q2
$2.64M Buy
14,335
+2,436
+20% +$436K 0.03% 259
2019
Q1
$2.26M Sell
11,899
-3,949
-25% -$754K 0.03% 268
2018
Q4
$3.08M Sell
15,848
-2,980
-16% -$581K 0.05% 249
2018
Q3
$3.9M Buy
18,828
+1,000
+6% +$197K 0.05% 237
2018
Q2
$3.29M Sell
17,828
-45
-0.3% -$7.96K 0.05% 245
2018
Q1
$3.05M Buy
17,873
+2,150
+14% +$395K 0.05% 251
2017
Q4
$2.73M Hold
15,723
0.04% 258
2017
Q3
$2.93M Buy
15,723
+310
+2% +$54.9K 0.05% 256
2017
Q2
$2.65M Buy
15,413
+675
+5% +$110K 0.04% 257
2017
Q1
$2.42M Buy
14,738
+2,420
+20% +$402K 0.04% 254
2016
Q4
$1.8M Sell
12,318
-1,525
-11% -$230K 0.03% 271
2016
Q3
$2.31M Buy
13,843
+25
+0.2% +$4.23K 0.04% 257
2016
Q2
$2.1M Buy
13,818
+2,150
+18% +$334K 0.04% 265
2016
Q1
$1.75M Sell
11,668
-110
-0.9% -$16.3K 0.03% 272
2015
Q4
$1.91M Sell
11,778
-930
-7% -$146K 0.04% 261
2015
Q3
$1.76M Sell
12,708
-1,490
-10% -$235K 0.03% 265
2015
Q2
$2.18M Buy
14,198
+133
+0.9% +$21.3K 0.03% 251
2015
Q1
$2.25M Sell
14,065
-550
-4% -$86.6K 0.03% 244
2014
Q4
$2.33M Buy
14,615
+600
+4% +$93.5K 0.03% 239
2014
Q3
$1.97M Buy
14,015
+335
+2% +$43.7K 0.03% 240
2014
Q2
$1.62M Buy
13,680
+8,375
+158% +$969K 0.02% 246
2014
Q1
$654K Sell
5,305
-20,000
-79% -$2.43M 0.01% 275
2013
Q4
$2.89M Buy
25,305
+2,605
+11% +$296K 0.04% 213
2013
Q3
$2.54M Buy
22,700
+19,800
+683% +$2.15M 0.04% 212
2013
Q2
$286K Buy
+2,900
New +$301K ﹤0.01% 298

Other funds holding AMGN

Boston Trust Walden's AMGN Position: Q2 2026 in Review

Boston Trust Walden reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $590K and leaving 82,829 shares worth $30M. The position accounts for 0.23% of the portfolio, ranked #149.

Boston Trust Walden first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $47.5M in Q2 2021. 1,172 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Boston Trust Walden held 82,829 shares of Amgen worth $30M as of Q2 2026.
  • Boston Trust Walden sold 1,723 Amgen shares in Q2 2026, an estimated $590K.
  • Amgen made up 0.23% of Boston Trust Walden's portfolio in Q2 2026, its #149 holding.
  • Boston Trust Walden first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Boston Trust Walden's Amgen position peaked at $47.5M in Q2 2021.
  • 1,172 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.